Target intelligence / Profile preview

Gut–brain neuroimmune axis

Molecular classification
Other
01

Overview

The gut–brain neuroimmune axis is a complex, bidirectional communication network that integrates the central nervous system (CNS), the enteric nervous system (ENS), the immune system, and the gut microbiota [1]. This axis facilitates the exchange of signals through various pathways, including the vagus nerve, the hypothalamic-pituitary-adrenal (HPA) axis, and the production of microbial metabolites like short-chain fatty acids [2]. It plays a critical role in maintaining physiological homeostasis, regulating intestinal barrier integrity, and modulating neuroinflammation [3]. Dysregulation of the gut–brain neuroimmune axis has been linked to the pathogenesis of diverse conditions, including Parkinson's disease, depression, irritable bowel syndrome, and multiple sclerosis [1][4]. While not a single molecular target, the axis represents a therapeutic framework where interventions such as probiotics, prebiotics, and vagus nerve stimulation are used to influence systemic and central health [2]. Understanding the interplay between gut-derived immune cells and brain-resident microglia is essential for developing novel treatments for neuroinflammatory disorders [3].

Other names
Microbiota-gut-brain axisGut-brain-immune axisNeuro-immune-endocrine axisEnteric-CNS-immune network
02

Mechanism of action

Modulation of bidirectional signaling between the gastrointestinal tract and the central nervous system via neural (vagus nerve), endocrine (HPA axis), and immunological (cytokines) pathways [1][4].

03

Biological functions

Immune responseSignal transductionHomeostasisNeurotransmissionMetabolic regulation
04

Disease associations

Neurodegenerative diseaseInflammationPsychiatric disorderGastrointestinal disorderAutoimmune disease
05

Safety considerations

Microbiome dysbiosisSystemic immune modulation risksVariable patient response to live biotherapeuticsPotential for unintended neurobehavioral changes
06

Interacting drugs

Probiotics

4 more in the full profile.

07

Biomarkers

Short-chain fatty acids (SCFAs)ZonulinCalprotectinInterleukin-6 (IL-6)Cortisol

Beyond the preview

Go deeper on Gut–brain neuroimmune axis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut–brain neuroimmune axis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call